Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, today announced that its European patent EP3722434, ...

FutureWise Research, a leading global market intelligence firm, today released a landmark report on Plasmid DNA Manufacturing ...

Company seeks strategic partners to advance novel PlaCCine technologyLAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc.

First DNA Cancer Vaccine Commercial Approval Expected By 2030 Says Kuick ResearchDelhi, Oct. 16, 2025 (GLOBE NEWSWIRE) -- ...

Experts at the Wellcome Sanger Institute, the University of Bath, the UK Health Security Agency (UKHSA) and their collaborators, analyzed over 40,000 plasmids from historical and present-day bacterial ...

Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...

Prof. Kabiru Akinyemi of the Department of Microbiology, Faculty of Science, Lagos State University (LASU) has sought the ...

This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...

Angelica Meyer highlights downstream bioprocessing challenges, emphasizing quality, innovation, and advancing transformative therapies.

Russian scientists have created a bacterial strain and a corresponding vaccine for animals that protects simultaneously against salmonellosis and colibacillosis, reports the official website of the ...

The company said the new chemistry could decrease sequencing costs for high-throughput users by up to 40%, lowering the ...